Investors

Growth Strategy

Three Growth Strategies

At TSO3 we are pursuing three distinct growth strategies to drive value for the industry and our shareholders:

  1. Support the global introduction and commercialization of our newest product the STERIZONE® low temperature sterilizer
  2. Broaden the portfolio with the development and commercialization of new products:
    • Purpose-built or sterilizer products
    • Geographic iterations of existing systems for local market acceleration
  3. Acquire complementary technology or product lines
    • Focus on the Healthcare Sterile Reprocessing market segment

TSO3 continues to evaluate its manufacturing operations and options to obtain the highest quality systems assembled at the lowest possible cost.